155 related articles for article (PubMed ID: 31635766)
1. FDG-PET Imaging of Salivary Gland Tumors.
Larson CR; Wiggins RH
Semin Ultrasound CT MR; 2019 Oct; 40(5):391-399. PubMed ID: 31635766
[TBL] [Abstract][Full Text] [Related]
2.
Broski SM; Johnson DR; Packard AT; Hunt CH
PET Clin; 2022 Apr; 17(2):249-263. PubMed ID: 35232668
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of neck node status using 18F-FDG PET for salivary duct carcinoma of the major salivary glands.
Kim JY; Lee SW; Kim JS; Kim SY; Nam SY; Choi SH; Roh JL; Choi EK; Kim JH; Song SY; Yoon SM; Kim YS; Kim SS; Park JH; Shin HS; Chang SK; Ahn SD
J Nucl Med; 2012 Jun; 53(6):881-6. PubMed ID: 22573820
[TBL] [Abstract][Full Text] [Related]
4. The impact of FDG-PET in the management of patients with salivary gland malignancy.
Otsuka H; Graham MM; Kogame M; Nishitani H
Ann Nucl Med; 2005 Dec; 19(8):691-4. PubMed ID: 16444995
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.
Roh JL; Ryu CH; Choi SH; Kim JS; Lee JH; Cho KJ; Nam SY; Kim SY
J Nucl Med; 2007 Feb; 48(2):240-6. PubMed ID: 17268021
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.
Khan N; Oriuchi N; Ninomiya H; Higuchi T; Kamada H; Endo K
Ann Nucl Med; 2004 Jul; 18(5):409-17. PubMed ID: 15462403
[TBL] [Abstract][Full Text] [Related]
7. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
Sharma P; Jain TK; Singh H; Suman SK; Faizi NA; Kumar R; Bal C; Malhotra A; Kumar R
Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886
[TBL] [Abstract][Full Text] [Related]
8. [(18)F-fluorodeoxy glucose positron emission tomography/computed tomography manifestation and clinical characteristics of primary salivary gland-type lung cancer].
Ding CY; Li YY; Sun J; Guo Z; Li TR
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):288-293. PubMed ID: 31014054
[No Abstract] [Full Text] [Related]
9. Sialadenoma papilliferum in the buccal mucosa detected on
Miyamoto S; Ogawa T; Chikazu D
Br J Oral Maxillofac Surg; 2017 Sep; 55(7):727-729. PubMed ID: 28625410
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors.
Uchida Y; Minoshima S; Kawata T; Motoori K; Nakano K; Kazama T; Uno T; Okamoto Y; Ito H
Clin Nucl Med; 2005 Mar; 30(3):170-6. PubMed ID: 15722820
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic role of (18)F-FDG-PET or PET/CT in salivary gland tumors: A systematic review.
Bertagna F; Nicolai P; Maroldi R; Mattavelli D; Bertoli M; Giubbini R; Lombardi D; Treglia G
Rev Esp Med Nucl Imagen Mol; 2015; 34(5):295-302. PubMed ID: 26488055
[TBL] [Abstract][Full Text] [Related]
12. FDG PET in detecting primary and recurrent malignant salivary gland tumors.
Cermik TF; Mavi A; Acikgoz G; Houseni M; Dadparvar S; Alavi A
Clin Nucl Med; 2007 Apr; 32(4):286-91. PubMed ID: 17413575
[TBL] [Abstract][Full Text] [Related]
13. Can dual-time-point 18F-FDG PET/CT differentiate malignant salivary gland tumors from benign tumors?
Toriihara A; Nakamura S; Kubota K; Makino T; Okochi K; Shibuya H
AJR Am J Roentgenol; 2013 Sep; 201(3):639-44. PubMed ID: 23971458
[TBL] [Abstract][Full Text] [Related]
14. Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas.
Horiuchi C; Tsukuda M; Taguchi T; Ishiguro Y; Okudera K; Inoue T
Ann Nucl Med; 2008 Oct; 22(8):693-8. PubMed ID: 18982472
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland tumors: pretherapy evaluation with PET.
Keyes JW; Harkness BA; Greven KM; Williams DW; Watson NE; McGuirt WF
Radiology; 1994 Jul; 192(1):99-102. PubMed ID: 8208973
[TBL] [Abstract][Full Text] [Related]
16. Frequency and malignancy rate of incidental focal salivary gland lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
Danstrup CS; Lyhne NM; Kovacsne A; Fisker R; Zacho HD
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):357-364. PubMed ID: 35939059
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
[TBL] [Abstract][Full Text] [Related]
18. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.
Kim MJ; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2013 Mar; 20(3):899-905. PubMed ID: 23161114
[TBL] [Abstract][Full Text] [Related]
19. "Quasi-symmetric" FDG avidity of bilateral salivary glands in Mikulicz disease yielding false-positive staging in lung cancer.
Lin LF; Shen DH; Tsai WC; Hou CH; Cheng CY; Chen CY
Clin Nucl Med; 2012 Nov; 37(11):1102-4. PubMed ID: 22996254
[TBL] [Abstract][Full Text] [Related]
20. State-of-the-Art Imaging of Salivary Gland Tumors.
Abdel Razek AAK; Mukherji SK
Neuroimaging Clin N Am; 2018 May; 28(2):303-317. PubMed ID: 29622121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
